Multicellular living organisms and unmodified parts thereof and – Nonhuman animal
Reexamination Certificate
2005-06-14
2005-06-14
Wilson, Michael (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
C800S003000
Reexamination Certificate
active
06906237
ABSTRACT:
We report the use of telomerase-immortalized human microvascular endothelial cells in the formation of functional capillary blood vessels in vivo. Previously we showed the superior in vitro survival of human telomerase reverse transcriptase (hTERT)-transduced human endothelial cells. Here we show that retroviral-mediated transduction of hTERT in human dermal microvascular endothelial cells (HDMEC) results in cell lines that form microvascular structures when subcutaneously implanted in severe combined immunodeficiency (SCID) mice. The human origin of xenografted microvaculature was confirmed both by basement membrane immunoreactivity with anti-human type IV collagen staining and visualization of fluorescent vessels containing HDMEC that were co-transduced with hTERT and green fluorescent protein (eGFP). The lack of human vascular structures after implantation of HT1080 fibrosarcoma cells, 293 human embryonic kidney cells or human skin fibroblasts demonstrated the specificity of HDMEC at forming capillaries. Intravascular red fluorescent microspheres injected into the host circulation were found within green “telomerized” microvessels indicating functional murine-human vessel anastamoses. Whereas primary HDMEC-derived vessel density decreased steadily with time, telomerized HDMEC maintained durable vessels 6 weeks after xenografting. Modulation of implant vessel density by exposure to different angiogenic and angiostatic factors demonstrated the utility of this system for the study of human microvascular remodeling in vivo.
REFERENCES:
patent: 5602305 (1997-02-01), Pober et al.
patent: 6166178 (2000-12-01), Cech et al.
patent: WO 9924565 (1999-05-01), None
patent: WO 00/56898 (2000-09-01), None
Thomas,Jan. 2000, Nature Biotech. vol. 18, pp. 39-42.
Yang,1999, Jour. Biol. Chem., vol. 274, pp. 26141-26148.
Okabe, 1997, FEBS Letters, vol. 407, 313-319.
Bunk,2001,The Scientist, vol. 15, p. 21.
Prewett,1999, Cancer Research, vol. 59, pp. 5209-5218.
Ueno,1997, Arter.Thromb. Vasc. Biol., vol. 17, pp. 2453-2460.
Yang, T. (2001). “Telomerized Human Microvasculature Is Functional In Vivo,”Nature Biotechnology19:219-224.
Bertoglio Valarie
Fenwick & West LLP
Wilson Michael
LandOfFree
Vivo assay for anti angiogenic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vivo assay for anti angiogenic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vivo assay for anti angiogenic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3481309